KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Beginning Cash Balance: 2010-2015

Historic Beginning Cash Balance for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to $17.7 million.

  • Biocryst Pharmaceuticals' Beginning Cash Balance fell 85.37% to $17.7 million in Q4 2015 from the same period last year, while for Dec 2015 it was $25.6 million, marking a year-over-year increase of 21.15%. This contributed to the annual value of $6.1 million for FY2024, which is 96.84% down from last year.
  • Biocryst Pharmaceuticals' Beginning Cash Balance amounted to $17.7 million in Q4 2015, which was down 76.91% from $76.8 million recorded in Q3 2015.
  • Biocryst Pharmaceuticals' Beginning Cash Balance's 5-year high stood at $121.5 million during Q3 2014, with a 5-year trough of $5.7 million in Q2 2012.
  • Its 3-year average for Beginning Cash Balance is $46.4 million, with a median of $23.6 million in 2013.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first surged by 514.76% in 2014, then slumped by 85.37% in 2015.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Beginning Cash Balance stood at $22.4 million in 2011, then grew by 6.76% to $24.0 million in 2012, then grew by 8.73% to $26.1 million in 2013, then skyrocketed by 365.09% to $121.2 million in 2014, then tumbled by 85.37% to $17.7 million in 2015.
  • Its last three reported values are $17.7 million in Q4 2015, $76.8 million for Q3 2015, and $48.4 million during Q2 2015.